CMMB

1.68

3.70% 0.06

Dopo l'orario di chiusura: 1.67 -0.01 -0.60%

Chemomab Therapeutics Ltd Adr (CMMB)

Panoramica Notizia Cronologia dei prezzi Financials Forum Previsione

Precedente Chiudi:

$1.62

Aprire:

$1.62

Volume 24 ore:

42,083

Relative Volume:

0.13

Capitalizzazione di mercato:

$31.68M

Reddito:

Utile/perdita netta:

$-33.08M

Rapporto P/E:

-0.5714

EPS:

-2.94

Flusso di cassa netto:

$-25.68M

1 W Prestazione:

-1.75%

1M Prestazione:

-19.62%

6M Prestazione:

-9.68%

1 anno Prestazione:

+148.15%

Intervallo 1D:

$1.62

$1.71

Intervallo di 1 settimana:

$1.4324

$1.74

Portata 52W:

$0.579

$2.55

Chemomab Therapeutics Ltd Adr Stock (CMMB) Company Profile

Nome

Chemomab Therapeutics Ltd Adr

Settore

Healthcare (1185)

Industria

Biotechnology (679)

Telefono

972-77-331-0156

Indirizzo

KIRYAT ATIDIM, BUILDING 7, TEL AVIV

Dipendente

Cinguettio

Prossima data di guadagno

2024-11-14

Ultimi documenti SEC

CMMB's Discussions on Twitter

Confronta CMMB con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
CMMB Chemomab Therapeutics Ltd Adr	1.68	31.68M	0	-33.08M	-25.68M	-2.94
VRTX Vertex Pharmaceuticals Inc	479.79	123.21B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	698.74	76.39B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	624.67	37.96B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	246.75	31.94B	2.25B	-278.16M	-42.59M	-2.17
ONC Beone Medicines Ltd Adr	271.80	29.00B	3.32B	-860.46M	-1.04B	-8.32

Chemomab Therapeutics Ltd Adr Stock (CMMB) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-05-13	Iniziato	Maxim Group	Buy
2024-05-06	Aggiornamento	Oppenheimer	Perform → Outperform
2023-12-19	Ripresa	ROTH MKM	Buy

Chemomab Therapeutics Ltd Adr Borsa (CMMB) Ultime notizie

Feb 20, 2025

Chemomab Therapeutics (CMMB) Stock Price, News & Analysis - MarketBeat

Feb 20, 2025

Feb 19, 2025

How analysts predict Chemomab Therapeutics Ltd ADR (CMMB) will perform this quarter? - US Post News

Feb 19, 2025

Jan 09, 2025

LogicMark Inc (LGMK) Recovers 0.71% From Low: Are We There Yet? - Stocks Register

Jan 09, 2025

Nov 19, 2024

Oral Presentation at AASLD The Liver Meeting® 2024 Highlights Broad Clinical Activity of Chemomab’s CM-101 Across Multiple Biomarkers and Its Disease-Modifying Potential in Primary Sclerosing Cholangitis - GlobeNewswire Inc.

Nov 19, 2024

Nov 14, 2024

Chemomab Therapeutics Announces Third Quarter 2024 Financial Results and Provides Corporate Update - Investing.com

Nov 14, 2024

Oct 15, 2024

Chemomab reports progress in PSC treatment trial - Investing.com

Oct 15, 2024

Sep 20, 2024

Roth MKM Initiates Coverage of Chemomab Therapeutics LtdADR (CMMB) with Buy Recommendation - MSN

Sep 20, 2024

Sep 16, 2024

The Chemomab Therapeutics Ltd ADR (CMMB) had a good session last reading, didn’t it? - US Post News

Sep 16, 2024

Sep 13, 2024

Financial Health Check: Examining Chemomab Therapeutics Ltd ADR (CMMB)’s Key Ratios - The Dwinnex

Sep 13, 2024

Sep 09, 2024